Episomal Induced Pluripotent Stem Cells: Functional and Potential Therapeutic Applications

18Citations
Citations of this article
71Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The term episomal induced pluripotent stem cells (EiPSCs) refers to somatic cells that are reprogrammed into induced pluripotent stem cells (iPSCs) using non-integrative episomal vector methods. This reprogramming process has a better safety profile compared with integrative methods using viruses. There is a current trend toward using episomal plasmid reprogramming to generate iPSCs because of the improved safety profile. Clinical reports of potential human cell sources that have been successfully reprogrammed into EiPSCs are increasing, but no review or summary has been published. The functional applications of EiPSCs and their potential uses in various conditions have been described, and these may be applicable to clinical scenarios. This review summarizes the current direction of EiPSC research and the properties of these cells with the aim of explaining their potential role in clinical applications and functional restoration.

Cite

CITATION STYLE

APA

Wang, A. Y. L., & Loh, C. Y. Y. (2019, December 1). Episomal Induced Pluripotent Stem Cells: Functional and Potential Therapeutic Applications. Cell Transplantation. SAGE Publications Ltd. https://doi.org/10.1177/0963689719886534

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free